Trial Profile
Stop TPO-receptor agonist in ITP Patients
Status:
Recruiting
Phase of Trial:
Phase II
Latest Information Update: 20 Nov 2017
Price :
$35
*
At a glance
- Drugs Romiplostim (Primary)
- Indications Idiopathic thrombocytopenic purpura
- Focus Therapeutic Use
- Acronyms STIP study
- 20 Nov 2017 New trial record